文献速递乳腺癌放疗放疗物理与技术

PI3Kαδ抑制剂联合放疗增强抗PD1在三阴性乳腺癌模型中的抗肿瘤免疫效果

PI3Kαδ Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-02-26

该研究在4T1小鼠三阴性乳腺癌模型中,采用24 Gy分3次放疗,联合PD-1阻断和PI3Kαδ抑制剂隔日给药2周,发现三联疗法显著延迟肿瘤生长并增强远隔效应,且该效应依赖免疫系统。

要点

  • 三联疗法显著延迟肿瘤生长,免疫缺陷小鼠中无此效果。
  • 放疗加PI3Kαδ抑制剂增加CD8+ T细胞比例,抑制剂减少Treg和PMN-MDSC。
  • 三联组远隔效应最显著,与脾脏CD8+ T细胞聚集相关。

核心结论

  • 放疗联合PI3Kαδ抑制剂和PD-1阻断可能克服免疫冷肿瘤的治疗抵抗。

研究设计与样本

  • 在免疫健全和免疫缺陷BALB/c小鼠中种植4T1乳腺癌细胞,放疗24 Gy分3次,PD-1阻断和PI3Kαδ抑制剂隔日给药2周。

主要发现

  • 三联疗法显著延迟肿瘤生长,免疫缺陷模型未显示该延迟。
  • 放疗加PI3Kαδ抑制剂增加CD8+ T细胞比例,PI3Kαδ抑制剂减少调节性T细胞和多形核髓源性抑制细胞。
  • 三联疗法显著增加细胞毒性CD8+ T细胞,远隔效应最显著且与脾脏CD8+ T细胞积累相关。

临床怎么用

  • 提示放疗联合PI3Kαδ抑制剂和PD-1阻断可作为改善免疫抑制性肿瘤微环境乳腺癌治疗的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The poor response of breast cancer to immune checkpoint blockade might result from low immunogenicity and the immune-suppressive tumor microenvironment. We hypothesized that in situ tumor vaccination via radiation therapy (RT) and suppression of immune tolerance via phosphoinositide 3-kinase δ (PI3Kδ) inhibition would enhance the efficacy of immune checkpoint blockade. METHODS AND MATERIALS: 4T1 murine breast cancer cells were grown in both immune-competent and -deficient BALB/c mice, and tumors were irradiated with 24 Gy in 3 fractions. A PD-1 blockade and a PI3Kαδ inhibitor were then administered every other day for 2 weeks. Fluorescence-activated cell sorting and immunohistochemistry served to monitor subsequent changes in immune cell repertoire. RESULTS: The triple combination of RT, PD-1 blockade, and PI3Kαδ inhibitor significantly delayed tumor growth. The immune-deficient syngeneic 4T1 murine tumor model failed to show this tumor growth delay. Use of RT and PI3Kαδ inhibitor increased the proportions of CD8+ T cells; PI3Kαδ inhibitor led to a decrease in regulatory T cells and polymorphonuclear myeloid-derived suppressor cells. The triple combination resulted in a remarkable increase in cytotoxic CD8+ T cells, suggesting a prominent immune-modulatory effect. The abscopal effect was most prominent in the triple-combination therapy group, and it correlated with splenic CD8+ T cell accumulation. CONCLUSIONS: These findings collectively indicate that combining RT, PI3Kαδ inhibitor, and PD-1 blockade could be a viable approach, helping to overcome the therapeutic resistance of immunologically cold tumors, such as breast cancer, with an immunosuppressive tumor microenvironment.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Chang WI, Han MG, Kang MH, et al. PI3Kαδ Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model. Int J Radiat Oncol Biol Phys. 2021. PMID: 33642128. doi:10.1016/j.ijrobp.2021.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。